Schedule 13G ownership disclosure

ALDER BIOPHARMACEUTICALS INC

Security class unavailable · CUSIP: 014339105

Event date: 2018-04-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,419,954
Percent of class
5.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-18-025415
Form type
SC 13G
Filer
ALDER BIOPHARMACEUTICALS INC
CIK
CIK 1423824
Filed
May 04, 2018
Reporting period
Apr 30, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub